| http://purl.uniprot.org/citations/7731726 | http://www.w3.org/1999/02/22-rdf-syntax-ns#type | http://purl.uniprot.org/core/Journal_Citation |
| http://purl.uniprot.org/citations/7731726 | http://www.w3.org/1999/02/22-rdf-syntax-ns#type | http://purl.uniprot.org/core/Citation |
| http://purl.uniprot.org/citations/7731726 | http://www.w3.org/2000/01/rdf-schema#comment | "Activation of MAP kinase/Erk Kinase (MEK) via direct phosphorylation by Mos may be crucial for cellular transformation by the activated c-mos or v-mos gene. Recent studies on a number of different protein kinases showed that phosphorylation within a subdomain of the catalytic domain may represent a common mode of activation. In this regard, activation of MEK1 by Raf involves phosphorylation of serine residues 218 and 222. Here we show that recombinant kinase-inactive MEK1 is phosphorylated by v-Mos with equal efficiency at both Ser 218 and Ser 222 in vitro. Tryptic phosphopeptide analysis of glutathione-S-transferase (GST)-MEK1 K97R and its alanine-for-serine mutants indicated that Ser 222 is the preferred phosphorylation site. Wild-type GST-MEK1 was phosphorylated at the same sites but contained a significantly lower amount of doubly phosphorylated species then its K97R kinase-inactive mutant. The ratio of GST-MEK1 species phosphorylated at two serines to those phosphorylated at one serine was similar in auto-phosphorylated and v-Mos-phosphorylated GST-MEK1. Consistent with the in vitro data, phosphopeptide mapping of MEK1 immunoprecipitated from mos transformed cells showed an increased amount of singly phosphorylated phosphopeptide compared to nontransformed cels. MEK1 was found to be more highly activated in NIH3T3 cells transformed by an activated c-mos or v-mos gene than in cells growing normally in medium containing serum. Our data indicate that Mos activated MEK1 in vitro as well as in vivo by phosphorylating Ser 222."xsd:string |
| http://purl.uniprot.org/citations/7731726 | http://purl.uniprot.org/core/author | "Guan K.L."xsd:string |
| http://purl.uniprot.org/citations/7731726 | http://purl.uniprot.org/core/author | "Singh B."xsd:string |
| http://purl.uniprot.org/citations/7731726 | http://purl.uniprot.org/core/author | "Zheng C.F."xsd:string |
| http://purl.uniprot.org/citations/7731726 | http://purl.uniprot.org/core/author | "Arlinghaus R.B."xsd:string |
| http://purl.uniprot.org/citations/7731726 | http://purl.uniprot.org/core/author | "Pham C.D."xsd:string |
| http://purl.uniprot.org/citations/7731726 | http://purl.uniprot.org/core/date | "1995"xsd:gYear |
| http://purl.uniprot.org/citations/7731726 | http://purl.uniprot.org/core/name | "Oncogene"xsd:string |
| http://purl.uniprot.org/citations/7731726 | http://purl.uniprot.org/core/pages | "1683-1688"xsd:string |
| http://purl.uniprot.org/citations/7731726 | http://purl.uniprot.org/core/title | "Characterization of MEK1 phosphorylation by the v-Mos protein."xsd:string |
| http://purl.uniprot.org/citations/7731726 | http://purl.uniprot.org/core/volume | "10"xsd:string |
| http://purl.uniprot.org/citations/7731726 | http://www.w3.org/2004/02/skos/core#exactMatch | http://purl.uniprot.org/pubmed/7731726 |
| http://purl.uniprot.org/citations/7731726 | http://www.w3.org/2004/02/skos/core#exactMatch | http://purl.uniprot.org/pubmed/7731726 |
| http://purl.uniprot.org/citations/7731726 | http://xmlns.com/foaf/0.1/primaryTopicOf | https://pubmed.ncbi.nlm.nih.gov/7731726 |
| http://purl.uniprot.org/citations/7731726 | http://xmlns.com/foaf/0.1/primaryTopicOf | https://pubmed.ncbi.nlm.nih.gov/7731726 |
| http://purl.uniprot.org/enzyme/2.7.12.2 | http://purl.uniprot.org/core/citation | http://purl.uniprot.org/citations/7731726 |
| http://purl.uniprot.org/uniprot/#_P31938-mappedCitation-7731726 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/7731726 |
| http://purl.uniprot.org/uniprot/P31938 | http://purl.uniprot.org/core/mappedCitation | http://purl.uniprot.org/citations/7731726 |